Mesoblast
$2.04Change from previous close: −1.45%Absolute change: −$0.03
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- $2.65B
- Enterprise value
- $2.68B
- Forward P/E
- 17.5
- PEG
- 0.13
- Price/book
- 3.26
- Price/sales
- 22.0
- EV/EBITDA
- -60.0
- EV/revenue
- 22.3
Profitability and growth
- Gross margin
- 80.0%
- Operating margin
- -33.3%
- Net margin
- -47.8%
- ROE
- -9.9%
- ROA
- -4.1%
- Revenue growth (year over year)
- 390.7%
Financial health
- Total cash
- $102.91M
- Total debt
- $127.33M
- Debt/equity
- 0.22
- Current ratio
- 2.44
- Quick ratio
- 1.98
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $3.64
- Median price target
- $3.56
- High price target
- $4.45
- Low price target
- $2.90
- Analysts with a price target
- 3
- Consensus
- Strong buy
- Forward EPS
- $0.12
- EPS estimate, current year
- -$0.01
Shares and trading
- Beta
- 0.82
- Average volume
- 2.83M
- Shares outstanding
- 1.3B
- Float
- 861.1M
- Institutional ownership
- 17.5%
- Insider ownership
- 36.3%